| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/GLIA.23245 |
| P698 | PubMed publication ID | 29068088 |
| P50 | author | Jason R Plemel | Q39420528 |
| P2093 | author name string | Peter K Stys | |
| Vikas V Patel | |||
| Shawn N Whitehead | |||
| Khalil S Rawji | |||
| V Wee Yong | |||
| Michael B Keough | |||
| James A Rogers | |||
| Belinda Heyne | |||
| Nina Weishaupt | |||
| Jaehyun Lim | |||
| Andrew V Caprariello | |||
| Nathan J Michaels | |||
| Samuel K Jensen | |||
| Wulin Teo | |||
| Aran Yukseloglu | |||
| P2860 | cites work | Pervasive axonal transport deficits in multiple sclerosis models | Q86078929 |
| GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5 | Q28246106 | ||
| G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine | Q28274505 | ||
| Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4 | Q28295925 | ||
| Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms | Q28299617 | ||
| Cell culture-based profiling across mammals reveals DNA repair and metabolism as determinants of species longevity | Q28588140 | ||
| Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS | Q28589814 | ||
| Remyelination protects axons from demyelination-associated axon degeneration | Q29302305 | ||
| Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP | Q29547505 | ||
| Dealing with Danger in the CNS: The Response of the Immune System to Injury | Q30279070 | ||
| High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial | Q30572344 | ||
| Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia | Q31962510 | ||
| Troponin C-based biosensors: a new family of genetically encoded indicators for in vivo calcium imaging in the nervous system | Q33282486 | ||
| Human microglial cells synthesize albumin in brain | Q33355985 | ||
| Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain | Q33548977 | ||
| Retinoid X receptor gamma signaling accelerates CNS remyelination | Q33580095 | ||
| Spatial elucidation of spinal cord lipid- and metabolite- regulations in amyotrophic lateral sclerosis | Q33741671 | ||
| Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus | Q33746029 | ||
| Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. | Q33882403 | ||
| Oligodendroglia metabolically support axons and contribute to neurodegeneration. | Q34032818 | ||
| Interaction of membrane proteins and lipids with solubilizing detergents | Q34088676 | ||
| An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. | Q34123789 | ||
| Correlation of membrane/water partition coefficients of detergents with the critical micelle concentration | Q34173030 | ||
| Axonal damage: a key predictor of outcome in human CNS diseases | Q34174912 | ||
| Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions | Q34280654 | ||
| Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemia | Q34323295 | ||
| Alterations of plasma lysophosphatidylcholine species in obesity and weight loss | Q34395775 | ||
| Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo | Q34472745 | ||
| Remyelination can be extensive in multiple sclerosis despite a long disease course | Q34578773 | ||
| Resistance of cell membranes to different detergents | Q35022104 | ||
| Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans | Q35058625 | ||
| Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury | Q35061098 | ||
| Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. | Q35076145 | ||
| Axoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons | Q35084174 | ||
| Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination | Q35132066 | ||
| Phospholipase A2 superfamily members play divergent roles after spinal cord injury | Q35609640 | ||
| Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction | Q35741256 | ||
| Mechanisms of lysophosphatidic acid production | Q35844014 | ||
| Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury | Q35851510 | ||
| Differential Anatomical Expression of Ganglioside GM1 Species Containing d18:1 or d20:1 Sphingosine Detected by MALDI Imaging Mass Spectrometry in Mature Rat Brain | Q35863925 | ||
| An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination | Q35999574 | ||
| Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination | Q36299698 | ||
| Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination | Q36344854 | ||
| No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse | Q37074091 | ||
| Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. | Q37181286 | ||
| Two pathways for lysophosphatidic acid production | Q37214057 | ||
| Unraveling the complexities of the HDL lipidome | Q37222656 | ||
| Curvature generation and pressure profile modulation in membrane by lysolipids: insights from coarse-grained simulations | Q37392578 | ||
| In vitro modeling of central nervous system myelination and remyelination | Q37920850 | ||
| The translational biology of remyelination: past, present, and future | Q38180416 | ||
| LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes | Q38368000 | ||
| The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. | Q38621895 | ||
| Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis. | Q38713422 | ||
| E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord | Q38934165 | ||
| Drug discovery for remyelination and treatment of MS. | Q39375830 | ||
| Remyelination therapies: a new direction and challenge in multiple sclerosis | Q39420410 | ||
| Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity | Q39492965 | ||
| Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. | Q39656987 | ||
| Sodium dependence of lysophosphatidylcholine-induced caspase-1 activity and reactive oxygen species generation. | Q39676612 | ||
| Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain | Q39745199 | ||
| Lysophosphatidylcholine induces glial cell activation: role of rho kinase | Q39900527 | ||
| Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. | Q40191448 | ||
| Interactions between axons and their sheath cells | Q40304707 | ||
| Interaction of detergents with lipid vesicles | Q40462748 | ||
| What are lipoproteins doing in the brain? | Q40872027 | ||
| Foamy virus as a gene transfer vector to the central nervous system. | Q41121819 | ||
| An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis. | Q41411691 | ||
| Antagonistic Functions of MBP and CNP Establish Cytosolic Channels in CNS Myelin | Q41827381 | ||
| Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain | Q41955077 | ||
| Interaction of lysophosphatidylcholine with central-nervous-system myelin | Q42922334 | ||
| NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. | Q43097105 | ||
| Demyelination versus remyelination in progressive multiple sclerosis. | Q44651982 | ||
| Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease | Q44757991 | ||
| Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling | Q44934799 | ||
| SPONTANEOUS ENCEPHALOMYELITIS OF MICE--A NEW VIRUS DISEASE. | Q45400821 | ||
| Anti-inflammatory actions of phosphatidylinositol. | Q45919766 | ||
| Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. | Q46157039 | ||
| Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry | Q46334122 | ||
| Reactivity towards singlet oxygen of propofol inside liposomes and neuronal cells. | Q46476706 | ||
| What determines the CSF concentrations of albumin and plasma-derived IgG? | Q47862358 | ||
| Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study | Q48290095 | ||
| Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells | Q48467171 | ||
| Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. | Q48580352 | ||
| Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury | Q48616515 | ||
| Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window | Q49076970 | ||
| Multiple stages of detergent-erythrocyte membrane interaction—A spin label study | Q50556322 | ||
| A functional role for EGFR signaling in myelination and remyelination. | Q50674097 | ||
| MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. | Q51065015 | ||
| T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS | Q57090609 | ||
| Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair | Q58425790 | ||
| Role of cytosolic phospholipase A2 in allergic response and parturition | Q59069879 | ||
| Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism | Q60498985 | ||
| Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm | Q73311913 | ||
| MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord | Q74096662 | ||
| Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination | Q80952967 | ||
| Myelination and the trophic support of long axons | Q83162670 | ||
| Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells | Q83516314 | ||
| A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis | Q83729196 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 327-347 | |
| P577 | publication date | 2017-10-25 | |
| P1433 | published in | Glia | Q15716658 |
| P1476 | title | Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy | |
| P478 | volume | 66 |
| Q64057248 | An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases |
| Q92716939 | Benefits of hesperidin in central nervous system disorders: a review |
| Q90732168 | Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells |
| Q90397729 | Co-administration of aspirin and adipose-derived stem cell conditioned medium improves the functional recovery of the optic pathway in a lysolecithin-induced demyelination model |
| Q64277249 | Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown |
| Q92664687 | In vivo real-time dynamics of ATP and ROS production in axonal mitochondria show decoupling in mouse models of peripheral neuropathies |
| Q90608717 | Inhibition of Piezo1 attenuates demyelination in the central nervous system |
| Q92806880 | Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination |
| Q93371129 | Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma |
| Q97519954 | Longitudinal Intravital Microscopy Reveals Axon Degeneration Concomitant With Inflammatory Cell Infiltration in an LPC Model of Demyelination |
| Q90168203 | Magnetic Resonance Imaging as a Biomarker in Rodent Peripheral Nerve Injury Models Reveals an Age-Related Impairment of Nerve Regeneration |
| Q93055838 | Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion |
| Q91818544 | Models and treatments for traumatic optic neuropathy and demyelinating optic neuritis |
| Q97426027 | Myelin Basic Protein Phospholipid Complexation Likely Competes with Deimination in Experimental Autoimmune Encephalomyelitis Mouse Model |
| Q90452789 | Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease |
| Q92317168 | Schema-like learning and memory consolidation acting through myelination |
| Q64105224 | TRPA1 Activation-Induced Myelin Degradation Plays a Key Role in Motor Dysfunction After Intracerebral Hemorrhage |
Search more.